National Planning Corporation’s First Trust NYSE Arca Biotechnology Index Fund FBT Stock Holding History

National Planning Corporation’s Portfolio FBT Stock Details FBT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q1	–	Sell	-2,689	Closed	-$218K	–	681
2015 Q4	$218K	Sell	2,689 -2,314	-46%	-$249K	0.02%	604
2015 Q3	$554K	Sell	5,003 -1,247	-20%	-$148K	0.05%	324
2015 Q2	$754K	Sell	6,250 -110	-2%	-$13.3K	0.07%	262
2015 Q1	$723K	Buy	6,360 +1,243	+24%	+$141K	0.06%	268
2014 Q4	$533K	Buy	5,117 +1,392	+37%	+$136K	0.04%	384
2014 Q3	$342K	Buy	3,725 +352	+10%	+$30.5K	0.03%	522
2014 Q2	$278K	Buy	3,373 +583	+21%	+$44.6K	0.02%	579
2014 Q1	$220K	Buy	+2,790	New	+$218K	0.02%	618

Other funds holding FBT

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

RJA

Raymond James & Associates St Petersburg, Florida $164B AUM 33.91% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

Jane Street New York $777B AUM 61.18% 1-Year Est. Return

TRCT

Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

National Planning Corporation's FBT Position: Q1 2016 in Review

National Planning Corporation sold out of First Trust NYSE Arca Biotechnology Index Fund (FBT) in Q1 2016, closing a stake of 2,689 shares — an estimated $218K sold.

National Planning Corporation first reported a position in FBT in Q1 2014 and held it in 8 quarters. The position peaked at $754K in Q2 2015. 107 funds tracked by Wall St. Rank hold FBT as of Q1 2016.

National Planning Corporation reported no remaining First Trust NYSE Arca Biotechnology Index Fund position as of Q1 2016 after selling out during the quarter.
National Planning Corporation sold 2,689 First Trust NYSE Arca Biotechnology Index Fund shares in Q1 2016, an estimated $218K.
National Planning Corporation first reported a position in First Trust NYSE Arca Biotechnology Index Fund in Q1 2014 and held it in 8 quarters.
National Planning Corporation's First Trust NYSE Arca Biotechnology Index Fund position peaked at $754K in Q2 2015.
107 funds tracked by Wall St. Rank held First Trust NYSE Arca Biotechnology Index Fund as of Q1 2016.

Based on National Planning Corporation's 13F filing for Q1 2016, filed 16 May 2016.